Genenta Science S.p.A. (GNTA) - Dilution Analysis

Visualizing historical and potential share dilution over time

View Stock Details

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Dilution Analysis

Low Risk

Limited dilution potential

Last updated: March 28, 2025

Risk Assessment Details

Potential Dilution: 0.0% of current shares

Recent Dilution: 0% (2 years)

Historical Dilution Factor: minimal recent dilution

Outstanding Shares

18M

Potential Supply

Additional shares possible

Splits

None

Past 2 years

Summary

GNTA currently has 18.3M outstanding shares. with minimal authorized share overhang for future dilution. The company has not diluted shareholders through share issuances in the past 2 years, which is positive for existing holders.

Share Structure Timeline

Outstanding Shares

Total Supply

Historical Data Points

Date	Event	Outstanding
Mar 28, 2025	20-F filing \| 18.3M shares outstanding	18M
Mar 29, 2024	20-F filing \| 18.2M shares outstanding	18M
May 12, 2023	F-3 filing: Genenta Science S.p.A. may offer and sell ordinary shares; ordinary shares represented by American depositary shares (ADSs); rights exercisable for ordinary shares and/or ordinary shares represented by ADSs, with a total aggregate offering price of up to $100,000,000.	18M
Apr 21, 2023	20-F filing \| 18.2M shares outstanding	18M
May 02, 2022	20-F filing \| 18.2M shares outstanding	18M
Nov 09, 2021	F-1 filing: Genenta S.p.A. is filing an F-1 for a public offering of ordinary shares, including an initial public offering of American Depositary Shares (ADSs) and a concurrent offering to existing shareholders in Italy.	15M

Back to GNTA Details